Advances in the oral delivery of proteins

Bibliography

• WEARLEY LL: Recent progress in protein and peptide delivery by noninvasive routes. Grit. Rev. Ther. Drug Carrier Syst. (1991) 8:331–394.
   PubMed Web of Science ®Google Scholar
• •Interesting review on approaches for protein delivery via non-invasive routes.
   Google Scholar
• SAYANI PA, CHIEN YW: Systemic delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug Carrier Syst. (1996) 13:85–184.
   PubMed Web of Science ®Google Scholar
• •Recent review on protein delivery via non-invasive routes.
   Google Scholar
• Peptide and Protein Drug Delivery Lee VHL (Ed.), Marcel Dekker, New York (1991).
   Google Scholar
• ••Contains comprehensive reviews and discussions on thepossibilities for protein delivery via non-invasive routes.
   Google Scholar
• LEE VHL, YAMAMOTO A: Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Del. Rev. (1990) 4:171–207.
   Google Scholar
• SMITH PL, WALL DA, GOCHOCO CH, WILSON G: Routes of delivery: case studies. 5. Oral absorption of peptides and proteins. Adv. Drug Del. Rev. (1992) 8:253–290.
   Web of Science ®Google Scholar
• ••Interesting discussion about the potential for the oral deliv-ery of proteins of different formulation strategies.
   Google Scholar
• AUNGST BJ: Novel formulation strategies for improv- ing oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. (1993) 82:979–987.
   PubMed Web of Science ®Google Scholar
• ••Interesting review on the oral delivery of proteins.
   Google Scholar
• FIX JA: Oral controlled release technology for pep- tides: status and future prospects. Pharm. Res. (1996) 13:1760–1763.
   PubMed Web of Science ®Google Scholar
• ••Discusses the possibilities for the development of oral for-mulations of proteins.
   Google Scholar
• WANG W: Oral protein drug delivery. J. Drug Target. (1996) 4:195–232.
   PubMed Web of Science ®Google Scholar
• ••Recent review on strategies for the oral delivery of proteins.
   Google Scholar
• MATTHEWS DM: Protein Absorption. Wiley, New York (1991).
   Google Scholar
• WOODLEY JF: Enzymatic barriers for GI peptide and protein delivery. Grit. Rev. Ther. Drug Carrier Syst. (1994) 11:61–95.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review on the difficulties and approaches toprevent the degradation of proteins in the gastrointestinal tract.
   Google Scholar
• MACKAY M, TOMLINSON E: Colonic delivery of thera-peutic peptides and proteins. In: Colonic Drug Absorp-tion and Metabolism. Bieck P (Ed.), Dekker, New York (1993) 159–176.
   Google Scholar
• ASHFORD M, FELL JT: Targeting drugs to the colon: de-livery systems for oral administration. J. Drug Target. (1994) 2:241–258.
   PubMed Web of Science ®Google Scholar
• VAN DEN MOOTER G, KINGET R: Oral colon-specific drug delivery: a review. Drug Delivery (1995) 2:81–93.
   Google Scholar
• RUBINSTEIN A: Approaches and opportunities in colon-specific site delivery. Grit. Rev. Ther. Drug Carrier Syst. (1995) 12:101–149.
   PubMed Web of Science ®Google Scholar
• TOUITOU E, RUBINSTEIN A: Targeted enteral delivery of insulin to rats. Int. J. Pharm. (1986) 30:95–99.
   Web of Science ®Google Scholar
• SAFFRAN M, KUMAR GS, SAVARIER C, BURNHAM JC, WIL-LIAMS F, NECKERS DC: A new approach to the oral ad-ministration of insulin and other peptide drugs. Science (1986) 233:1081–1084.
   PubMed Web of Science ®Google Scholar
• SAFFRAN M, KUMAR GS, NECKERS DC, PENA J, JONES RH,FIELD JB: Biodegradable azopolymer coating for oral delivery of peptide drugs. Biochem. Soc. Trans. (1991) 18:752–754.
   Google Scholar
• SAFFRAN M, FIELD JB, PENA J, JONES RH, OKUDA Y: Oralinsulin in diabetic dogs. J. Endocrinol (1991) 131:267–278.
   PubMed Web of Science ®Google Scholar
• BRONDSTED H, KOPECEK J: Hydrogels for site-specificdrug delivery to the colon: in vitro and in vivo degrada-tion. Pharm. Res. (1992) 9:1540–1545.
   PubMed Web of Science ®Google Scholar
• RUBINSTEIN A, RADAI R, EZRA M, PATHAK S, ROKEM JS:In vitro evaluation of calcium pectinate: a potential colonic-specific drug delivery carrier. Pharm. Res. (1993) 10:258–263.
   PubMed Web of Science ®Google Scholar
• CHENG CL, GEHRKE SH, RITSCHEL WA: Development ofan azopolymer based colonic release capsule for deliv-ering proteins/macromolecules. Methods Find. Exp. Pharmacol. (1994) 16:271–278.
   PubMed Web of Science ®Google Scholar
• TOZAKI H, EMI Y, HORISAKA E, FUJITA T, YAMAMOTO A,MURANISHI S: Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colon. J. Pharm. Pharmacol (1997) 49:164–168.
   PubMed Web of Science ®Google Scholar
• LASKOWSKI M, HEASSLER HA, MIECH RP, PEANASKY RJ,LASKOWSKI M: Effect of trypsin inhibitor on passage of insulin across the intestinal barrier. Science (1958) 127:1115–1116.
   PubMed Web of Science ®Google Scholar
• DANFORTH E, Jr., MOORE RO: Intestinal absorption of insulin in the rat. Endocrinology (1959) 65:118–123.
   PubMedGoogle Scholar
• KIDRON M, BAR-ON J, BERRY EM, ZIV E: The absorption of insulin from various regions of the rat intestine. Life Sci. (1982) 31:2837–2841.
   PubMed Web of Science ®Google Scholar
• FUJII S, YOKOYAMA T, IKEGAYA K, SATO F, YOKOO N:Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J. Pharm. Pharmacol. (1985) 37:545–549.
   PubMed Web of Science ®Google Scholar
• SHINOMIYA M, SHIRAI K, SAITO Y, YOSHIDA S, MAT-SUOKA N: Effect of new chymotrypsin inhibitor (FK-448) on intestinal absorption of insulin. Lancet (1985) 1:1092–1093.
   PubMedGoogle Scholar
• YAMAMOTO A, TANIGUCHI T, RIKYUU K et al.: Effect ofvarious protease inhibitors on the intestinal absorp-tion and degradation of insulin in rats. Pharm. Res. (1994) 11:1496–1500.
   PubMed Web of Science ®Google Scholar
• LEE VHL: Protease inhibitors and penetration enhan-cers as approaches to modify peptide absorption. J. Controlled Release (1991) 13:213–223.
   Google Scholar
• KIMURA T, SATO K, SUGIMOTO K et al: Oral administra-tion of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. Biol. Pharm. Bull. (1996) 19:897–900.
   PubMed Web of Science ®Google Scholar
• WATANABE S, TAKEUCHI T, CHEY WY: Mediation oftrypsin inhibitor-induced pancreatic hypersecretion by secretion and cholecystokinin in rats. Gastroenterol-ogy (1992) 102:621–628.
   PubMedGoogle Scholar
• ABUCHOWSKI A, DAVIS FF: Soluble polymers-enzyme adducts. In: Enzymes as Drugs. Holcenberg S (Ed.), Wiley, New York (1981) 368–383.
   Google Scholar
• DELGADO C, FRANCIS GE, FISHER D: The uses and prop-erties of PEG-linked proteins. Grit. Rev. Ther. Drug Car-rier Syst. (1992) 9:249–304.
   PubMed Web of Science ®Google Scholar
• FUKE I, HAYASHI T, TABATA Y, IKADA Y: Synthesis of poly (ethylene glycol) derivatives with different branchings and their use for protein modification. J. Controlled Release (1994) 30:27–34.
   Web of Science ®Google Scholar
• DONALDSON RM: Intrinsic factor and the transport of cobalamin. In: Physiology of the Gastrointestinal Tract. Johnson LR (Ed.), Raven Press, New York (1987) 959–973.
   Google Scholar
• RUSSELL-JONES GJ, AIZPURNA HJ: Vitamin B12: a novel carrier for orally presented antigens. Proc. Int. Symp. Contr. Rel. Bioact. Mater. (1988) 15:142–143.
   Google Scholar
• DIX CJ, HASSAN IF, OBRAY HY, SHAH R, WILSON G: The transport of vitamin B12 through polarized monolay-ers of Caco-2 cells. Gastroenterology (1990) 98:1272–1279.
   PubMed Web of Science ®Google Scholar
• CHO YW, FLYNN M: Oral delivery of insulin. Lancet (1989) 2:1518–1519.
   PubMed Web of Science ®Google Scholar
• RITSCHEL WA: Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol. (1991) 13:205–220.
   PubMed Web of Science ®Google Scholar
• ZHOU XH, PO ALW: Peptide and protein drugs: II. Non-parenteral routes of delivery. Int. J. Pharm. (1991) 75:117–130.
   Google Scholar
• HO H-0, HSIAO C-C, SHEU M-T: Preparation of microe-mulsions using polyglycerol fatty acid esters as surfac-tant for the delivery of protein drugs. J. Pharm. Sci. (1996) 85:138–143.
   PubMed Web of Science ®Google Scholar
• CUNHA AS, GROSSIORD JL, PUISIEUX F, SEILLER M: Insu-lin in w/o/w multiple emulsions: biological activity af-ter oral administration in normal and diabetic rats. J. Microencapsul. (1997) 14:321–333.
   PubMed Web of Science ®Google Scholar
• SHIVELY ML: Multiple emulsions for the delivery of proteins. Pharm. Biotechnol. (1997) 10:199–211.
   PubMedGoogle Scholar
• BAI JP, CHANG LL, GUO JH: Effects of polyacrylic poly-mers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin. J. Pharm. Pharmacol. (1996) 48:17–21.
   PubMed Web of Science ®Google Scholar
• NEW RCC, LITTLEWOOD GM, CRIPPS D, KIRBY CJ, GUARD P, FLYNN MJ: Enteral delivery of insulin in nor-mal humans using an oil-based Macrosoff formula-tion. Proc. Int. Symp. Contr. Rel. Bioact. Mater. (1997) 24: 339–340.
   Google Scholar
• KAWADA J, TANAKA N, NOZAKI Y: Non reduction of blood glucose in diabetic rats after oral administration of insulin liposomes prepared under acidic condi-tions. Endocrinol. Jpn. (1981) 28:235–238.
   PubMedGoogle Scholar
• SHENFIELD GM, HILL JC: Infrequent response by dia-betic rats to insulin-liposomes. Clin. Exp. Pharmacol. Physiol (1982) 9:355–361.
   PubMed Web of Science ®Google Scholar
• PATEL HM, STEVENSON RW, PARSONS JA, RYMAN BE: Use of liposomes to aid intestinal absorption of en-trapped insulin in normal and diabetic dogs. Biochim. Biophys. Acta (1982) 716:188–193.
   PubMed Web of Science ®Google Scholar
• ARRIETA-MOLERO JF, ALECK K, SINHA MK, BROWNSCHNEIDLE CM, SHAPIRO LJ, SPERLING MA: Orally administered liposome-entrapped insulin in diabetic animals. Horm. Res. (1982) 16:249–256.
   PubMed Web of Science ®Google Scholar
• WOODLEY JF: Liposomes for oral administration of drugs. Grit. Rev. Ther. Drug Carrier Syst. (1985) 2:1–18.
   PubMedGoogle Scholar
• CHOUDHARI KB, LABHASETWAR V, DORLE AK: Lipo-somes as a carrier for oral administration of insulin: effect of formulation factors. J. Microencapsul. (1994) 11:319–325.
   PubMed Web of Science ®Google Scholar
• RAO LS: Liposomal dosage form development-some practical considerations. J. Parenter. Sci. Technol (1983) 37:72–75.
   PubMedGoogle Scholar
• LEONE-BAY A, SANTIAGO N, ACHAN D et al: N-Acylated a-amino acids as novel oral delivery agents for pro-teins. J. Med. Chem. (1995) 38:4263–4269.
   PubMed Web of Science ®Google Scholar
• LEONE-BAY A, HO K-K, AGARWAL R et al.: 444-[(2-Hydroxybenzoyl) amino] phenylibutyric acid as a novel oral delivery agent for recombinant human growth hormone. J. Med. Chem. (1996) 39:2571–2578.
   PubMedGoogle Scholar
• BRAYDEN D, CREED E, O'CONNELL A, LEIPOLD H, AGAR-WAL R, LEONE-BAY A: Heparin absorption across the intestine: effects of sodium N48-(2-hydroxybenzoyfiaminolcaprylate in rat in situ intesti-nal instillations and in Caco-2 monolayers. Pharm. Res. (1997) 14:1772–1779.
   PubMed Web of Science ®Google Scholar
• MILSTEIN SJ, LEIPOLD H, SARUBBI D et al.: Oral bioavail-ability of partially folded proteins. J. Controlled Release (In Press).
   Google Scholar
• FLORENCE AT: The oral absorption of micro- and nano-particles: neither exceptional nor unusual. Pharm. Res. (1997) 14:259–266.
   PubMed Web of Science ®Google Scholar
• •Contains interesting discussions about the potential of bio-degradable particles for the oral delivery of protein drugs.
   Google Scholar
• O'HAGAN DT: The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat. (1996) 189:477–482.
   Google Scholar
• THOMAS NW, JENKINS PG, HOWARD KA et al.: Particle uptake and translocation across epithelial mem-branes. J. Anat. (1996) 189:487–490.
   PubMedGoogle Scholar
• KREUTER J: Nanoparticles. In: Colloidal Drug Delivery Sys-tems. Kreuter J (Ed.), Marcel Dekker, New York (1994) 219–342.
   Google Scholar
• OKADA H, TOGUCHI H: Biodegradable microspheresin drug delivery. Grit. Rev. Ther. Drug Carrier Syst. (1995) 12:1–99.
   PubMed Web of Science ®Google Scholar
• GOMBOTZ WR, DEAN KP: Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem. (1995) 6:332–351.
   PubMed Web of Science ®Google Scholar
• HAZZARD RA, HODGES GM, SCOTT JD, MCGUINNESS CB, CARR KE: Early intestinal microparticle uptake in the rat. J Anat. (1996) 189:265-271. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (1998) 8(3)
   Google Scholar
• CARR KE, HAZZARD RA, REID S, HODGES GM: The effect of size on uptake of orally administered latex micro-particles in the small intestine and transport to mesen-teric lymph nodes. Pharm. Res. (1996) 13:1205–1209.
   PubMed Web of Science ®Google Scholar
• DAMGE C, APRAHAMIAN M, MARCHAIS H, BENOIT JP, PINGET M: Intestinal absorption of PLAGA micro-spheres in the rat. J. Anat. (1996) 1996:491–501.
   Google Scholar
• JANI P, HALBERT GW, LANGRIDGE J, FLORENCE AT: Nanoparticle uptake by the rat gastrointestinal mu-cosa: quantitation and particle size dependency. J. Pharm. Pharmacol (1990) 42:821–826.
   PubMed Web of Science ®Google Scholar
• ELDRIDGE JM, GILLEY RM, STAAS JK, MOLDOVEANU Z, MUELBROCEK JA, TICE TR: Biodegradable micro-spheres: vaccine delivery system for oral immuniza-tion. Curr. Topics Micro. Immunol. (1989) 146:59–66.
   PubMed Web of Science ®Google Scholar
• ELDRIDGE JM, MUELBROEK JA, STAAR JK, TICE TR, GIL-LEY RM: Vaccine containing biodegradable micro-spheres specifically enter the gut-associated lymphoid tissue following oral administration and induce dis-seminated mucosal immune response. Adv. Exp. Biol. Med. (1989) 251:191–202.
   PubMedGoogle Scholar
• JENKINS PG, COOMBES AG, YEH MK, THOMAS NW, DAVIS SS: Aspects of the design and delivery of micro-particles for vaccine applications. J. Drug Target. (1995) 3:79–81.
   PubMed Web of Science ®Google Scholar
• DESAI MP, LABHASETWAR V, AMIDON GL, LEVY RJ: Gas-trointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. (1996) 13:1838–1845.
   PubMed Web of Science ®Google Scholar
• DAMGE C, MICHEL C, APRAHAMIAN M, COUVREUR P: New approach for the oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes (1988) 37:246–251.
   PubMed Web of Science ®Google Scholar
• MICHEL C, APRAHAMIAN M, DEFONTAINE L, COUVREUR P, DAMGE C: The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J. Pharm. Pharma-col. (1991) 43:1–5.
   PubMed Web of Science ®Google Scholar
• MATHIOWITZ E, JACOB JS, JONG YS et al.: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410–414.
   PubMed Web of Science ®Google Scholar
• LEHR C-M: Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier SysL (1994) 11:119–160.
   PubMed Web of Science ®Google Scholar
• •Interesting review on the use of mucoadhesive materials to enhance the absorption of protein drugs from the gastroin-testinal tract.
   Google Scholar
• BJORK E, ISAKSSON U, EDMAN P, ARTURSSON P: Starchmicrosphere induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. J. Drug Target. (1995) 2:501–507.
   PubMed Web of Science ®Google Scholar
• MUELLER SC, CHEN WT: Cellular invasion into matrixbeads: localization of beta 1 integrins and fibronectin to the invadopopia. J. Cell. Sci. (1991) 99:213–225.
   PubMed Web of Science ®Google Scholar
• KREUTER J: Nanoparticles and microparticles for drugand vaccine delivery. J. Anat. (1996) 189:503–505.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E: RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol. (1996) 12:697–715.
   PubMed Web of Science ®Google Scholar
• LEE VHL, YAMAMOTO A, KOMPELLA UB: Mucosal pene-tration enhancers for facilitaton of peptide and pro-tein drug absorption. Crit. Rev. Ther. Drug Carrier Syst. (1991) 8:91–192.
   PubMedGoogle Scholar
• MURANISHI S: Absorption enhancers. Crit. Rev. Ther. Drug Carrier SysL (1990) 7:1–33.
   PubMed Web of Science ®Google Scholar
• FIX JA: Strategies for delivery of peptides utilizing absorption-enhancing agents. J. Pharm. Sci. (1996) 85:1282–1285.
   PubMed Web of Science ®Google Scholar
• ANDERBERG EK, NYSTROM C, ARTURSSON P: Epithelialtransport of drugs in cell culture. VII: Effects of phar-maceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caro-2) cells. J. Pharm. Sci. (1992) 81:879–887.
   Google Scholar
• KAJII H, HORIE T, HAYASHI M, AWAZU S: Fluorescencestudy on the interaction of salicylate with rat small in-testinal epithelial cells: possible mechanism for the promoting effects of salicylate on drug absorption in vivo. Life Sci. (1985) 37:523–530.
   PubMed Web of Science ®Google Scholar
• NISHIHATA T, TOMIDA H, FREDERICK G, RYTTING JH,HIGUCHI T: Comparison of the effects of sodium sali-cylate, disodium ethylenediaminetetraacetic acid and polyoxyethylene-23-lauryl ether as adjuvants for the rectal absorption of sodium cefoxitin. J. Pharm. Sci. (1985) 37:159–163.
   Google Scholar
• TOMITA M, SHIGA M, HAYASHI M, AWAZU S: Enhance-ment of colonic drug absorption by the cellular per-meation route. Pharm. Res. (1988) 5:341–346.
   PubMed Web of Science ®Google Scholar
• HOCHMAN J, ARTHURSSON P: Mechanisms of absorp-tion enhancement and tight junction regulation. J. Controlled Release (1994) 29:253–267.
   Web of Science ®Google Scholar
• KAJII H, HORIE T, HAYASHI M, AWAZU S: Fluorescencestudy of the membrane-perturbing action of sodium caprylate as related to promotion of drug absorption. Pharm. Sci. (1988) 77:390–392.
   PubMedGoogle Scholar
• FIX JA, ENGLE K, PORTER PA et al.: Acylcarnitines: drugabsorption-enhancing agents in the gastrointestinal tract. Am. J. Physiol. (1986) 251:G332–G340.
   Google Scholar
• TAKAHASHI H, SHIBASAKI T, TAKESHITA K, KAIHO F,HAYASHI M: The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway. Biol. Pharm. (1997) 20:446–448.
   PubMedGoogle Scholar
• ANDERBERG EK, LINDMARK T, ARTURSSON P: Sodiumcaprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. (1993) 10:857–864.
   PubMed Web of Science ®Google Scholar
• SHAO Z, LI Y, KRISHNAMOORHY R, CHERMAK T, MITRAAK: Differential effects of anionic, cationic, nonionic, and physiologic surfactant on the dissociation, chy-motrypsin degradation, and enteral absorption of in-sulin hexamers. Pharm. Res. (1993) 10:243-250. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (1998) 8(3)
   Google Scholar
• NERURKAR MM, BURTON PS, BORCHARDT RT: The useof surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polar-ized efflux system. Pharm. Res. (1996) 13:528–534.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO A, HAYAKAWA E, KATO Y, NISHIURA A, LEEVHL: A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit. J. Pharma-col. Exp. Ther. (1992) 263:25–31.
   PubMed Web of Science ®Google Scholar
• SITHIGORNGUL P, BURTON P, NISHIHATA T, CALDWELL L: Effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: a light and electron micros-copy study. Life Sci. (1983) 33:1025–1032.
   PubMedGoogle Scholar
• PETERS GE, HUTCHINSON LEF, HYDE R, MCMARTIN C,METCALFE SB: Effects of sodium 5-methoxysalicylate on macromolecule absorption and mucosal morphol-ogy in a vasculary perfused rat gut preparation in vivo. Pharm. Sci. (1987) 76:857–861.
   PubMedGoogle Scholar
• SWENSON ES, MILISEN WB, CRATOLO W: Intestinal per-meation enhancement: structure-activity and structure-toxicity relationships for nonylphenoxy-polyoxyethylene surfactant permeability enhancers. Pharm. Res. (1994) 11:1501–1504.
   PubMed Web of Science ®Google Scholar
• ARTURSSON P, LINDMARK T, DAVIS SS, ILLUM L: Effect ofchitosan on the permeability of monolayers of intesti-nal epithelial cells (Caro-2). Pharm. Res. (1994) 11:1358–1361.
   PubMed Web of Science ®Google Scholar
• SCHIPPER NG, VARUM KM, ARTURSSON P: Chitosans asabsorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetyla-tion on drug transport across human intestinal epithe-lial (Caco-2) cells. Pharm. Res. (1996) 13:1686–1692.
   Google Scholar
• SCHIPPER NG, OLSSON S, HOOGSTRAATE JA, DEBOERAG, VARUM KM, ARTURSSON P: Chitosans as absorption enhancers for poorly absorbable drugs. 1. Mechanism of absorption enhancement. Pharm. Res. (1997) 14:923–929.
   Google Scholar
• HOCHMAN JH, FIX JA, LECLUYSE EL: In vitro and in vivo analysis of the mechanism of absorption enhance-ment by palmitoylcarnitine. J. Pharmacol Exp. Ther. (1994) 269:813–822.
   PubMed Web of Science ®Google Scholar
• LECLUYSE EL, SUTTON SC, FIX JA: In vitro effects of long-chain acylcarnitines on the permeability, transe-pithelial electrical resistance and morphology of rat colonic mucosa. J. Pharmacol Exp. Ther. (1993) 265:955–962.
   PubMed Web of Science ®Google Scholar
• HURNI MA, NOACH AB, BLOM-ROOSEMALEN MC, DE-BOER AG, NAGELKERKE JF, BREIMER DD: Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assess-ment of effect-reversibility and imaging of transepi-thelial transport routes by confocal laser scanning microscopy. J. Pharmacol. Exp. Ther. (1993) 267:942–950.
   PubMed Web of Science ®Google Scholar
• FASANO A, UZZAU S: Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. (1997) 99:1158–1164.
   PubMed Web of Science ®Google Scholar